Spectrum Vascular acquires catheter guidance tech developer Piccolo Medical

Mergers & Acquisitions
Spectrum Vascular has acquired Piccolo Medical, a developer of FDA-cleared catheter guidance technology, in a move aimed at strengthening its vascular access offerings. The acquisition centers on Piccolo’s PM2+ system, which uses proprietary blood flow...

Spectrum Vascular acquires catheter guidance tech developer Piccolo Medical

Mergers & Acquisitions
Spectrum Vascular has acquired Piccolo Medical, a developer of FDA-cleared catheter guidance technology, in a move aimed at strengthening its vascular access offerings. The acquisition...

Nyxoah secures $110M financing to accelerate U.S. launch of Genio

Funding
Nyxoah has secured $110 million in new capital to support the U.S. commercial expansion of its Genio implantable therapy for obstructive sleep apnea (OSA). The...

GS MedTech Funding Tracker – Novanta, CeQur, and more

GS Funding Tracker
Big capital and early innovation met this week in MedTech, with major financings in commercial-stage platforms and continued backing for emerging device and digital...

Airiver treats first patient in drug-coated balloon study for chronic rhinosinusitis

Clinical Trials
Airiver Medical has announced the first patient treatment in its RESTORE-2 pivotal clinical trial evaluating its ESSpand drug-coated balloon (DCB) for chronic rhinosinusitis (CRS). The...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Airiver treats first patient in drug-coated balloon study for chronic rhinosinusitis

Airiver Medical has announced the first patient treatment in its RESTORE-2 pivotal clinical trial evaluating its ESSpand drug-coated balloon (DCB) for chronic rhinosinusitis (CRS). The...

Anteris to expand global heart valve trial

Anteris Technologies announced that it received full regulatory clearance to expand its PARADIGM trial to France. The company - founded in Brisbane, Australia with a...

Neuronoff implants first patient in DOD-funded trial of Injectrode

Neuronoff, a clinical-stage neuromodulation company, announced the first patient implant in a Department of Defense (DOD) funded clinical trial evaluating the safety and efficacy...

Picard Medical’s SynCardia completes milestone study of next-gen total artificial heart

Picard Medical, parent company of SynCardia, announced the completion of an in vivo study of its Emperor platform. The company completed an acute in vivo...

Innovation

Regulatory Approvals

Spectrum Vascular acquires catheter guidance tech developer Piccolo Medical

Spectrum Vascular has acquired Piccolo Medical, a developer of FDA-cleared catheter guidance technology, in a move aimed at strengthening its vascular access offerings. The acquisition...

Nyxoah secures $110M financing to accelerate U.S. launch of Genio

Nyxoah has secured $110 million in new capital to support the U.S. commercial expansion of its Genio implantable therapy for obstructive sleep apnea (OSA). The...

GS MedTech Funding Tracker – Novanta, CeQur, and more

Big capital and early innovation met this week in MedTech, with major financings in commercial-stage platforms and continued backing for emerging device and digital...

Airiver treats first patient in drug-coated balloon study for chronic rhinosinusitis

Airiver Medical has announced the first patient treatment in its RESTORE-2 pivotal clinical trial evaluating its ESSpand drug-coated balloon (DCB) for chronic rhinosinusitis (CRS). The...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1155Regulatory Approvals1024Innovation655Clinical Trials526Mergers & Acquisitions511GS Funding Tracker53